Impact in total ischemic time and ST-segment elevation myocardial infarction admissions during COVID-19

Despite the COVID-19 pandemic, cardiovascular disease is still the main cause of death in developed countries. Of these deaths, acute coronary syndromes (ACS) account for a substantial percentage of deaths. Improvement in ACS outcomes, are achieved by reducing the time from symptom onset until reperfusion or total ischemic time (TIT). Nevertheless, due to the overwhelming reality at the beginning of the pandemic, acute coronary syndrome (ACS) care may have been compromised.

Source: The American Journal of Emergency Medicine - February 18, 2021 Category: Emergency Medicine Authors: Sharon Bruoha, Chaim Yosefy, Enrique Gallego-Colon, Jonathan Rieck, Yan Orlov, Azriel Osherov, Abu Hamed Jihad, Yaniv Sherer, Nasi Viki, Jamal Jafari Source Type: research